2018 · Journal of pharmaceutical and biomedical analysis · paywalled
Volumetric absorptive MicroSampling vs. other blood sampling materials in LC-MS-based protein analysis - preliminary investigations
Andersen et al.
The finding, in our words
VAMS recovery relative to DMPK-C depended on the protein, being lower for β-lactoglobulin and myoglobin but higher for cytochrome c and albumin, and haematocrit affected protein quantification from both materials. VAMS showed strong correlation (R² ≥ 0.983), accuracy of 71 to 101 per cent and precision with RSD at or below 20 per cent for six model proteins spiked into blood, supporting its use for decentralised protein analysis with awareness of haematocrit effects.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
An LC-MS/MS assay using volumetric absorptive microsampling achieved 72.5% to 98.9% accuracy and under 8% precision for measuring circulating endocannabinoids and related lipid mediators. However, drying time significantly altered 2-AG and 2-OG concentrations, and marked differences were observed between whole blood and plasma measurements.
This proof-of-concept study compared VAMS and dried blood spot microsamples with fluid blood for untargeted lipidomic profiling using high-resolution LC-MS/MS, finding that VAMS is a viable option for untargeted lipidomics with the advantage of haematocrit independence over traditional dried blood spots.
Volumetric absorptive microsampling with the Mitra device enables accurate, reproducible quantification of circulating protein biomarkers from a 10 µL finger-prick blood sample, with extraction recovery of 100–111% across haematocrit levels and stable peptide responses after 22 weeks at -80°C. The automated mass spectrometry workflow reproducibly detected 1661 peptides from 423 proteins, correlating with plasma measurements, which supports remote, personalised disease monitoring.
Researchers successfully validated an analytical method for measuring creatinine across plasma and volumetric absorptive microsampling devices, demonstrating strong correlation between conventional plasma and dried microsamples. This provides a reliable, patient-centric approach for monitoring kidney function remotely during transplant follow-up.
In lung and renal transplant recipients, VAMS sampling with LC-MS/MS quantification of mycophenolic acid and tacrolimus showed good linearity and accuracy, and with a haematocrit-adjusted conversion formula achieved clinical agreement in most samples; tacrolimus did not require haematocrit correction. The approach is virtually painless and enables richer sampling for more accurate drug exposure estimates, supporting decentralised therapeutic drug monitoring.